<?xml version="1.0" encoding="UTF-8"?>
<ref id="R48">
 <label>48</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Cortese</surname>
    <given-names>I</given-names>
   </name>, 
   <name name-style="western">
    <surname>Muranski</surname>
    <given-names>P</given-names>
   </name>, 
   <name name-style="western">
    <surname>Enose-Akahata</surname>
    <given-names>Y</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Pembrolizumab treatment for progressive multifocal leukoencephalopathy</article-title>. 
  <source>N Engl J Med</source>
  <year>2019</year>;
  <volume>380</volume>:
  <fpage>1597</fpage>â€“
  <lpage>605</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1815039</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/30969503?>
  <pub-id pub-id-type="pmid">30969503</pub-id>
 </mixed-citation>
</ref>
